Digital Health in Cardiac Rehabilitation and Secondary Prevention: A Search for the Ideal Tool

Digital health is becoming more integrated in daily medical practice. In cardiology, patient care is already moving from the hospital to the patients’ homes, with large trials showing positive results in the field of telemonitoring via cardiac implantable electronic devices (CIEDs), monitoring of pulmonary artery pressure via implantable devices, telemonitoring via home-based non-invasive sensors, and screening for atrial fibrillation via smartphone and smartwatch technology. Cardiac rehabilitation and secondary prevention are modalities that could greatly benefit from digital health integration, as current compliance and cardiac rehabilitation participation rates are low and optimisation is urgently required. This viewpoint offers a perspective on current use of digital health technologies in cardiac rehabilitation, heart failure and secondary prevention. Important barriers which need to be addressed for implementation in medical practice are discussed. To conclude, a future ideal digital tool and integrated healthcare system are envisioned. To overcome personal, technological, and legal barriers, technological development should happen in dialog with patients and caregivers. Aided by digital technology, a future could be realised in which we are able to offer high-quality, affordable, personalised healthcare in a patient-centred way.

[1]  L. Stevenson,et al.  Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial , 2016, The Lancet.

[2]  Alan S. Go,et al.  Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction , 2020, Journal of the American Heart Association.

[3]  Robert West,et al.  Relative effectiveness of a full versus reduced version of the ‘Smoke Free’ mobile application for smoking cessation: an exploratory randomised controlled trial , 2018, F1000Research.

[4]  Louise Bowman,et al.  Screening for atrial fibrillation: a call for evidence , 2019, European heart journal.

[5]  F. Sanz,et al.  Towards a European health research and innovation cloud (HRIC) , 2020, Genome Medicine.

[6]  Alberto Ruano-Ravina,et al.  Participation and adherence to cardiac rehabilitation programs. A systematic review. , 2016, International journal of cardiology.

[7]  Edmund Seto,et al.  A Focused Review of Smartphone Diet-Tracking Apps: Usability, Functionality, Coherence With Behavior Change Theory, and Comparative Validity of Nutrient Intake and Energy Estimates , 2019, JMIR mHealth and uHealth.

[8]  A. Hoes,et al.  [Guidelines on cardiovascular disease prevention in clinical practice]. , 2005, Revue medicale de Liege.

[9]  Sunil V. Rao,et al.  Robotic Assisted Percutaneous Coronary Intervention: Hype or Hope? , 2019, Journal of the American Heart Association.

[10]  Matthew M. Burg,et al.  Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review , 2018, Journal of the American Heart Association.

[11]  Tenzin Wangmo,et al.  Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects , 2020, BMC Medical Ethics.

[12]  Thomas M Deserno,et al.  Unobtrusive Health Monitoring in Private Spaces: The Smart Vehicle , 2020, Sensors.

[13]  Paul Dendale,et al.  Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits , 2017, European journal of preventive cardiology.

[14]  M. Cowie,et al.  Remote Management of Heart Failure: An Overview of Telemonitoring Technologies , 2019, Cardiac failure review.

[15]  Giovanni Sparacino,et al.  Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors , 2020, Sensors.

[16]  Alhussein Albarbar,et al.  Review on Smart Electro-Clothing Systems (SeCSs) , 2019, Sensors.

[17]  Karim Ladha,et al.  Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial , 2018, The Lancet.

[18]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[19]  Logesh Ravi,et al.  A study on medical Internet of Things and Big Data in personalized healthcare system , 2018, Health Information Science and Systems.

[20]  Wenru Wang,et al.  The evolving mHealth-based cardiac rehabilitation. , 2019, The Lancet. Digital health.

[21]  A. Baranchuk,et al.  The Current State of Mobile Phone Apps for Monitoring Heart Rate, Heart Rate Variability, and Atrial Fibrillation: Narrative Review , 2019, JMIR mHealth and uHealth.

[22]  Marco V Perez,et al.  Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. , 2019, The New England journal of medicine.

[23]  Christina Holzapfel,et al.  A Scientific Overview of Smartphone Applications and Electronic Devices for Weight Management in Adults , 2019, Journal of personalized medicine.

[24]  Dorairaj Prabhakaran,et al.  2020 International Society of Hypertension Global Hypertension Practice Guidelines. , 2020, Hypertension.

[25]  Ann Blandford,et al.  Opportunities and challenges for telehealth within, and beyond, a pandemic , 2020, The Lancet Global Health.

[26]  Riccardo Miotto,et al.  Reflecting health: smart mirrors for personalized medicine , 2018, npj Digital Medicine.

[27]  Stefan Störk,et al.  Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial , 2018, The Lancet.

[28]  Urte Scholz,et al.  Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial , 2019, BMC Public Health.

[29]  Diederick Grobbee,et al.  Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry , 2019, European journal of preventive cardiology.

[30]  Takahiro Okumura,et al.  Development and Validation of a Novel Cuff-Less Blood Pressure Monitoring Device , 2017, JACC. Basic to translational science.

[31]  Amir Lerman,et al.  Vocal Biomarker Is Associated With Hospitalization and Mortality Among Heart Failure Patients , 2020, Journal of the American Heart Association.

[32]  Atul J Butte,et al.  A call for deep-learning healthcare , 2019, Nature Medicine.

[33]  D. Lipkin,et al.  Cardiac rehabilitation. , 1993, BMJ.

[34]  Roselien Buys,et al.  Accuracy of Apple Watch Measurements for Heart Rate and Energy Expenditure in Patients With Cardiovascular Disease: Cross-Sectional Study , 2019, JMIR mHealth and uHealth.

[35]  Raul I. Ramos-Garcia,et al.  Wearable Sensors for Monitoring of Cigarette Smoking in Free-Living: A Systematic Review , 2019, Sensors.

[36]  Ezio Soldati,et al.  Physical Activity Measured by Implanted Devices Predicts Atrial Arrhythmias and Patient Outcome: Results of IMPLANTED (Italian Multicentre Observational Registry on Patients With Implantable Devices Remotely Monitored) , 2018, Journal of the American Heart Association.

[37]  G. Hindricks,et al.  Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.

[38]  Sanjiv S. Gambhir,et al.  A mountable toilet system for personalized health monitoring via the analysis of excreta , 2020, Nature Biomedical Engineering.

[39]  Jae-Yoon Sim,et al.  Wireless smart contact lens for diabetic diagnosis and therapy , 2020, Science Advances.

[40]  Junbo Ge,et al.  Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial. , 2019, The Lancet. Digital health.

[41]  Goran Krstačić,et al.  ESC e-Cardiology Working Group Position Paper: Overcoming challenges in digital health implementation in cardiovascular medicine , 2019, European journal of preventive cardiology.

[42]  Vitaly Herasevich,et al.  Tele-Critical Care: An Update From the Society of Critical Care Medicine Tele-ICU Committee. , 2019, Critical care medicine.

[43]  Sajal K. Das,et al.  The Internet of People (IoP): A new wave in pervasive mobile computing , 2017, Pervasive Mob. Comput..

[44]  Marek Malik,et al.  e-Health: a position statement of the European Society of Cardiology. , 2016, European heart journal.

[45]  M. Krantz,et al.  Smartwatch detection of ventricular tachycardia: Case series , 2020, HeartRhythm case reports.

[46]  Guy Carrault,et al.  A New Wearable Device for Blood Pressure Estimation Using Photoplethysmogram , 2019, Sensors.

[47]  Mary A Whooley,et al.  Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. , 2007, Archives of internal medicine.

[48]  Dorairaj Prabhakaran,et al.  2020 International Society of Hypertension global hypertension practice guidelines. , 2020, Journal of hypertension.

[49]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[50]  T. Hastie,et al.  Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort , 2016, bioRxiv.

[51]  Amir Lerman,et al.  Voice Signal Characteristics Are Independently Associated With Coronary Artery Disease , 2018, Mayo Clinic proceedings.

[52]  Sebastiano Battiato,et al.  A Report on Smoking Detection and Quitting Technologies , 2020, International journal of environmental research and public health.

[53]  Olga Perski,et al.  Does the addition of a supportive chatbot promote user engagement with a smoking cessation app? An experimental study , 2019, Digital health.

[54]  Joseph G. Akar,et al.  Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform , 2020, npj Digital Medicine.

[55]  Florian Rader,et al.  The Slow Evolution of Blood Pressure Monitoring , 2017, JACC. Basic to translational science.

[56]  Siva K. Mulpuru,et al.  Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series. , 2017, Journal of the American College of Cardiology.

[57]  Paul Dendale,et al.  Patient experiences and willingness-to-pay for cardiac telerehabilitation during the first surge of the COVID-19 pandemic: single-centre experience , 2020, Acta cardiologica.

[58]  Allison N Tegge,et al.  A machine-learning approach to predicting smoking cessation treatment outcomes. , 2018, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[59]  G. Lip,et al.  2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. , 2018, Journal of hypertension.

[60]  Dirk De Bacquer,et al.  Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey , 2018, European journal of preventive cardiology.

[61]  Hua Lin,et al.  Current Status of HbA1c Biosensors , 2017, Sensors.

[62]  Aldo A. Faisal,et al.  Artificial Intelligence, Data Sensors and Interconnectivity: Future Opportunities for Heart Failure , 2019, Cardiac failure review.

[63]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[64]  J. Galanko,et al.  Initial Assessment of a Comprehensive Digital Smoking Cessation Program That Incorporates a Mobile App, Breath Sensor, and Coaching: Cohort Study , 2019, JMIR mHealth and uHealth.

[65]  Steven A. Lubitz,et al.  Population-Based Screening for Atrial Fibrillation. , 2020, Circulation research.

[66]  Anita Deswal,et al.  Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization , 2020, Circulation. Heart failure.

[67]  Hassaan A. Bukhari,et al.  The ‘Digital Twin’ to enable the vision of precision cardiology , 2020, European heart journal.

[68]  Amir Lerman,et al.  Non-invasive vocal biomarker is associated with pulmonary hypertension , 2020, PloS one.

[69]  Dominique Hansen,et al.  Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. , 2020, European journal of preventive cardiology.

[70]  Lorenz Koller,et al.  Expert Opinion: Meditation and Cardiovascular Health: What is the Link? , 2019, European cardiology.

[71]  Dominique Hansen,et al.  The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology , 2020, European journal of preventive cardiology.

[72]  Lionel Tarassenko,et al.  The Mobile-Based 6-Minute Walk Test: Usability Study and Algorithm Development and Validation , 2020, JMIR mHealth and uHealth.

[73]  Natalie Stein,et al.  A Fully Automated Conversational Artificial Intelligence for Weight Loss: Longitudinal Observational Study Among Overweight and Obese Adults , 2017, JMIR diabetes.

[74]  Paul Dendale,et al.  Use of cardiac telerehabilitation during COVID-19 pandemic in Belgium , 2020, Acta cardiologica.